1. |
Di Renzo MF, Narsimhan RP, Olivero M, et al. Expression of the MET/HGF receptor in normal and neoplastic human tissues 〔J〕. Oncogene, 1997; 6(11)∶2003.
|
2. |
Matsumoto K, Nakamura T. Hepatocyte growth factor(HGF) as a tissue organizer for organogenesis and regeneration 〔J〕. Biochem Biophys Res Commun, 1997; 239(3)∶639.
|
3. |
Weidner KM, Behrens J, Vandekerckhove J, et al. Scatter factor: molecular characteristics and effect on invasiveness of epithelial cells 〔J〕. J Cell Biol, 1990; 111(5)∶2097.
|
4. |
Rosen EM, Knesel J, Goldberg ID, et al. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor 〔J〕. Int J Cancer, 1994; 57(5)∶706.
|
5. |
Yamashita J, Ogawa M, Beppu T. Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines 〔J〕. Res Commun Chem Pathol Pharmacol, 1993; 82(2)∶249.
|
6. |
Rubin JS,Chan AM, Bottaro DP, et al. A broodspectrum human lung fibroblastderived mitogen is a variant of hepatocyte growth factor 〔J〕. Proc Natl Acad Sci USA, 1991; 88(2)∶415.
|
7. |
Rosenthal EL, Johnson TM, Allen ED, et al. Role of the plasminogen activator matrix metalloproteinase systems in epidermal growth factorand scatter factorstimulated invasion of carcinoma cells 〔J〕. Cancer Res, 1998; 58(22)∶5221.
|
8. |
Bostick PJ, Huynh KT, Sarantou T, et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiplemarker RTPCR 〔J〕. Int J Cancer, 1998; 79(6)∶645.
|
9. |
Yamashita J, Ogawa M, Yamashita S, et al. Immunoreactive Hepatocyte Growth Factor is a strong and independent predictor of recurrence and survival in human breast cancer 〔J〕. Cancer Res, 1994; 54(7)∶1630.
|
10. |
Tsarfaty I, Alvord WG, Resau JH, et al. Alteration of Met Protooncogene product expression and prognosis in breast carcinomas 〔J〕. Anal Quant Cytol Histol, 1999; 21(5)∶397.
|
11. |
Seslar SP, Nakamura T, Stephen WB. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors 〔J〕. Cancer Res, 1993; 53(6)∶1233.
|
12. |
Nakamura T, Matsumoto K, Kiritoshi A, et al. Induction of hepatocyte growth factor in fibroblasts by tumorderived factors affects invasive growth of tumor cells: in vitro analysis of tumorstromal interactions 〔J〕. Cancer Res, 1997; 57(15)∶3305.
|
13. |
Matsumoto TN, Matsumoto K, Nakamura T. Prostaglandin production in mouse mammary tumor cells confers in vasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts 〔J〕. Br J Cancer, 1999; 81(2)∶194.
|
14. |
Kuniyasu H, Yasui W, Kitadai Y, et al. Frequent amplification of the cmet gene in scirrhous type stomach cancer 〔J〕. Biochem Biophys Res Commun, 1992; 189(1)∶227.
|
15. |
Liu C, Park M, Tsao MS. Overexpression of cmet protooncogene but not epidermal growth factor receptor or cerb B2 in primary human colorectal carcinomas 〔J〕. Oncogene, 1992; 7(1)∶181.
|
16. |
Schulte KM, Antoch G, Ellrichmann M, et al. Regulation of the HGFreceptor cmet in the thyroid gland 〔J〕. Exp Clin Endocrinol Diabetes, 1998; 106(4)∶310.
|
17. |
Di Renzo MF, Olivero M, Katsaros D, et al. Overexpression of the MET/HGF receptor in ovarian cancer 〔J〕. Int J Cancer, 1994; 58(5)∶658.
|
18. |
Natali PG, Prat M, Nicotra MR, et al. Overexpression of the met/HGF receptor in renal cell carcinomas 〔J〕. Int J Cancer (Pred Oncol), 1996; 69(3)∶212.
|
19. |
Joseph A, Weiss GH, Jin L, et al. Expression of scatter factor in human bladder carcinoma 〔J〕. J Natl Cancer Inst, 1995; 87(5)∶372.
|
20. |
Furukawa T, Duguid WP, Kobari M, et al. Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis 〔J〕. Am J Pathol, 1995; 147(4)∶889.
|
21. |
Tsuka H, Mori H, Li B, et al. Expression of cmet/HGF receptor mRNA and protein in human nonmalignant and malignant prostate tissues 〔J〕. Int J Oncol, 1998; 13(5)∶927.
|
22. |
Kiss A, Wang NJ, Xie JP, et al. Analysis of transforming growth factor (TGF)alpha/epidermal growth factor, hepatocyte growth factor/cmet, TGFbeta receptor type Ⅱ, and p53 expression in human hepatocellular carcinoma 〔J〕. Clin Cancer Res, 1997; 3(7)∶1059.
|
23. |
Bussolino F, DI Renzo MF, Ziche M, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth 〔J〕. J Cell Biol, 1992; 119(3)∶629.
|